AUNAHealthcare · Medical Care FacilitiesThe 7 Wall Street analysts covering Auna SA hold a median 12-month price target of $6.9 — +31.7% from the last close. Ticker Nerd's systematic factor model, run across ~4,600 US stocks, ranks it 62 of 100 as at 15 Aug 2026 — in the upper half.
Consensus tells you what everyone already believes. The model scores Auna SA on its factor families — the same systematic rank behind the Ticker Nerd portfolio.
Percentile across ~4,600 US stocks on Ticker Nerd’s systematic factor model. Higher is better. How the model is built and tested
Value (96): The shares cost little relative to the profits and assets behind them — which can mean the market is too gloomy, or that the business really is in trouble.
Momentum (31): The shares have been drifting down relative to others.
Built and run by Aslam Ghouse, an ex-Goldman Sachs quant trader with fourteen years in markets.
The bullish and bearish analyst opinions on AUNA, reported as data — targets and ratings, the market's view beside the model's.
Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.
The green dot is the last close — the median target sits +31.7% from it.
| Date | Firm | Action | Rating | Target |
|---|---|---|---|---|
| 26 May 2026 | JP Morgan | Maintains | Neutral | $6.00 → $5.00 |
| 26 May 2026 | JP Morgan | Maintains | Neutral | — |
| 16 Jan 2026 | Jefferies | Initiates | Buy | — |
| 18 Nov 2025 | JP Morgan | Downgrade | Neutral | — |
| 11 Feb 2025 | JP Morgan | Maintains | Overweight | — |
| 20 Sept 2024 | JP Morgan | Maintains | Overweight | — |
| 20 Aug 2024 | JP Morgan | Maintains | Overweight | — |
| 23 Apr 2024 | HSBC | Initiates | Buy | — |
| 16 Apr 2024 | Citigroup | Initiates | Buy | — |
| 16 Apr 2024 | JP Morgan | Initiates | Overweight | — |
| 16 Apr 2024 | Morgan Stanley | Initiates | Overweight | — |
Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.
Computed off the Friday close and sent before the US open.
Market Radar reports the week’s largest rank changes across roughly 4,600 US stocks, the factor behind each one, and where the market went. AUNA appears on the weeks it earns a place.
Not the forecast itself — the direction analysts are revising it. Revision direction is one of the model's factor families.
A margin means little on its own. Each bar marks where the figure sits across the whole US universe we score.
Cheaper than 40% of US stocks
Cheaper than 97% of US stocks
Cheaper than 79% of US stocks
Cheaper than 53% of US stocks
Higher than 59% of US stocks
Higher than 4% of US stocks
Higher than 46% of US stocks
Higher than 70% of US stocks
Higher than 51% of US stocks
Higher than 53% of US stocks
Higher than 78% of US stocks
Bars mark the percentile across the ~4,600 US stocks Ticker Nerd covers, among those reporting the figure.
The nearest names by industry and size, scored by the same model — like for like.
Look up any of the roughly 4,600 stocks we score.
The rank is the raw material. Whether the rules would actually own Auna SA — and when they’d sell — is the membership. See the Ticker Nerd 20 →
Zacks Investment Research reported that Auna S.A. (AUNA) has the right combination of two key ingredients likely to produce an earnings beat in its upcoming report. The article highlights expectations going into the report.
Why it matters — AUNA watchers would care because the story signals the company is positioned to exceed earnings expectations in its next report.
The 7 Wall Street analysts covering Auna SA have a median 12-month price target of $6.9, with estimates ranging from $5 to $9. These are third-party analyst estimates, not Ticker Nerd forecasts, and they are frequently wrong.
Of the 7 analysts covering Auna SA, 5 rate it a Buy, 2 a Hold and 0 a Sell. Ticker Nerd's systematic factor model ranks Auna SA 62 out of 100 across roughly 4,600 US stocks as at 15 Aug 2026. None of this is personal advice — it does not consider your circumstances.
As at 15 Aug 2026, Auna SA ranks 62 out of 100 on Ticker Nerd's systematic factor model — a percentile across roughly 4,600 US stocks, built from its factor families. Its strongest factor family is Value (96 of 100).
No one can know that. What the data says: the median 12-month target from 7 analysts implies +31.7% from the last close, and Ticker Nerd's factor model ranks Auna SA 62 out of 100 as at 15 Aug 2026. Analyst targets are third-party estimates and frequently wrong; none of this is personal advice.
No analyst covering Auna SA publishes a 2030 price target — Wall Street targets run 12 to 18 months out. Sites quoting a 2030 price for AUNA are extrapolating price history, which says nothing about the business. The furthest attributed numbers are the current analyst targets: $5 to $9 over the next 12 months.
Auna SA returned -17.1% over the 12 months to 14 Aug 2026, with dividends reinvested. Past performance does not indicate future returns.
Auna S.A. is a healthcare services company that operates integrated medical platforms across Latin America.
The most recent item we track (Zacks Investment Research, 11 Aug 2026): "Auna S.A. (AUNA) Expected to Beat Earnings Estimates: Should You Buy?". Zacks Investment Research reported that Auna S.A. (AUNA) has the right combination of two key ingredients likely to produce an earnings beat in its upcoming report. The article highlights expectations going into the report.
Auna S.A. is a healthcare services company that operates integrated medical platforms across Latin America. Headquartered in Luxembourg and founded in 2022, the company focuses on providing comprehensive healthcare and medical services through hospitals, clinics, and specialized care centers. Auna S.A. is organized into segments including Oncosalud Peru, which offers oncology-focused services and prepaid cancer care plans, and broader Healthcare Services in Peru and Colombia, which encompass general medicine, surgery, diagnostics, and outpatient care. The company serves individuals, families, and corporate clients through prepaid healthcare plans, membership models, and direct care, aiming to improve access to organized, network-based medical services. By combining clinical services with preventive care programs, diagnostics, and specialty treatments, Auna S.A. plays a notable role in the healthcare sector in its core markets, contributing to the region’s private healthcare infrastructure and offering alternatives to public health systems and traditional insurance-based care structures.
CEO Mr. Jesús Antonio Zamora Leon · 14,796 employees · Luxembourg · https://www.aunainvestors.com